According to the latest report from TMR Research, the global coagulation analyzer market is expected to display double-digit growth rate by the end of the forecast period in 2025. Coagulation analyzers are used for multiple applications such as measuring blood prothrombin ratio for the diagnosis and analysis of a number of diseases and their developmental stages. With several countries across the globe increasingly investing in the improvement of healthcare infrastructures, this market has witnessed a huge surge in growth opportunities in the past few years.
The market includes a wide variety of semiautomatic as well as automatic varieties of coagulation analyzers, with the semiautomatic varieties requiring the involvement of clinical technicians to prepare and introduce samples.
The report divides the market by product, technology, test type, end-use, and geography.
Factors that are favoring the growth of the coagulation analyzer market in developing nations include increasing population base across the world suffering from chronic blood diseases and lifestyle associated disorders, the rising awareness about these conditions, the rising geriatric population, increasing prevalence of chronic diseases, and increasing foreign investments in developing economies.
However, the market faces challenges including stringent regulations for the approval of medical devices that make it difficult for small players to enter this marketplace. This, in turn, is challenging the market's growth.
Other key findings of the report include:
- In the product segment, consumables are expected to account for a significant share of the market in the future, due to the increasing testing volume and development of new assays.
- Optical technology is projected to exhibit the highest share of the market during the forecast period.
- North America is the largest regional market and is expected to contribute substantial revenue to the global market by 2025.
- Favorable healthcare norms combined with the rising prevalence of cardiometabolic disorders such as pulmonary embolism (PE) and deep vein thrombosis (DVT) are boosting the growth of this regional market.
- Due to the presence of an adequate number of hospitals, clinics, and health centers backed by skilled healthcare personnel that are equipped to deliver safe and effective services, the Middle East and Africa regional segments are expected to display significant growth.
Some of the leading players in this industry are Siemens Healthcare, Instrumentation Laboratory, Roche Diagnostics, Thermo Fischer Scientific, Sysmex Corporation, International Technidyne Corporation, Alere Inc., Beckman Coulter Inc., and NIHON KOHDEN.